Rapid Dose Therapeutics Corp. (DOSE.CN)
CAD 0.23
(-4.17%)
CAD 0.23
(-4.17%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.29 Million | -863.91 Thousand | -2.99 Million | -1.62 Million | -3.03 Million | -2.13 Million |
| Net Income | -4.3 Million | -3.81 Million | -8.48 Million | -2.29 Million | -7.96 Million | -11.39 Million |
| Depreciation & Amortization | 620.31 Thousand | 627.44 Thousand | 765.8 Thousand | 675.46 Thousand | 484.05 Thousand | 156.27 Thousand |
| Deferred income taxes | - | 28.61 Thousand | - | - | - | -62.69 Thousand |
| Stock-based compensation | 162.24 Thousand | 706.93 Thousand | 1.69 Million | - | 2.63 Million | 50 Thousand |
| Change in working capital | 488.68 Thousand | 1.46 Million | -1.2 Million | -71.45 Thousand | 1.32 Million | 1.45 Million |
| Other non-cash items | 1.57 Million | 120.97 Thousand | 4.23 Million | 70 Thousand | 484.18 Thousand | 7.66 Million |
| Investing Cash Flow | - | - | 1.85 Million | -9124.00 | 530.46 Thousand | -3.89 Million |
| Investments in PPE | 1.00 | - | -40.35 Thousand | -9124.00 | -1.22 Million | -1.66 Million |
| Acquisitions | - | - | 1.89 Million | - | 98.99 Thousand | - |
| Investment purchases | - | - | - | - | -98.99 Thousand | -2.22 Million |
| Sales/Maturities of investments | - | - | - | - | 1.65 Million | - |
| Other Investing Activities | - | - | 1198.00 | - | 98.99 Thousand | -2.22 Million |
| Financing Cash Flow | 2.42 Million | 856.52 Thousand | 1.12 Million | 1.64 Million | 1.24 Million | 6.96 Million |
| Debt repayment | -1.55 Million | -309.36 Thousand | -285.65 Thousand | -263.76 Thousand | -243.54 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.2 Million | 151.84 Thousand | 1.28 Million | 899.84 Thousand | 893.27 Thousand | 6.96 Million |
| Other Financing Activities | 1.2 Million | 1.01 Million | 1.41 Million | 1.01 Million | 592.85 Thousand | 6.96 Million |
| Accounts receivables | -67.32 Thousand | 21.13 Thousand | 202.64 Thousand | -144.28 Thousand | 190.82 Thousand | -203.6 Thousand |
| Accounts payables | 621.26 Thousand | 1.31 Million | -470.35 Thousand | 453.08 Thousand | 600.88 Thousand | 757.49 Thousand |
| Inventory | 12.58 Thousand | 78.57 Thousand | -39.65 Thousand | -192.99 Thousand | -71.53 Thousand | -97.85 Thousand |
| Other working capital | -77.84 Thousand | 48.78 Thousand | -900.36 Thousand | -187.25 Thousand | 607.69 Thousand | 1 Million |
| Cash at beginning of period | 27.58 Thousand | 34.44 Thousand | 70.26 Thousand | 3469.00 | 1.26 Million | 326.26 Thousand |
| Cash at end of period | 161.05 Thousand | 27.58 Thousand | 34.44 Thousand | 70.26 Thousand | 3469.00 | 1.26 Million |
| Capital Expenditure | 1.00 | - | -40.35 Thousand | -9124.00 | -1.22 Million | -1.66 Million |
| Effect of forex changes on cash | - | 534.00 | -18.63 Thousand | 50.62 Thousand | -3778.00 | 326.26 Thousand |
| Net cash flow / Change in cash | 133.47 Thousand | -6855.00 | -35.82 Thousand | 66.79 Thousand | -1.26 Million | 940.61 Thousand |
| Free Cash Flow | -2.29 Million | -863.91 Thousand | -3.03 Million | -1.63 Million | -4.25 Million | -3.79 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.09 Million | -1.25 Million | -4.3 Million | -2.05 Million | -981.07 Thousand | -730.68 Thousand |
| Depreciation & Amortization | 50.21 Thousand | 82.73 Thousand | 620.31 Thousand | 180.77 Thousand | 152.83 Thousand | 140.18 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 426.7 Thousand | 162.24 Thousand | 162.24 Thousand | - | - |
| Change in working capital | 428.69 Thousand | -101.19 Thousand | 488.68 Thousand | -181.07 Thousand | 64.57 Thousand | 331.26 Thousand |
| Other non-cash items | 490.47 Thousand | 897.22 Thousand | 1.57 Million | 1.36 Million | 75.9 Thousand | 76.02 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | -5.00 | 3.00 | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 88.89 Thousand | 574.31 Thousand | 2.42 Million | 1.28 Million | 650.52 Thousand | 353.83 Thousand |
| Debt repayment | -66.14 Thousand | -29.14 Thousand | -1.55 Million | -96.07 Thousand | -597 Thousand | -1.04 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 177.96 Thousand | 580.53 Thousand | 1.2 Million | 1.2 Million | -107.78 Thousand | 107.78 Thousand |
| Other Financing Activities | -22.92 Thousand | 22.92 Thousand | 1.2 Million | 1.45 Million | 250 Thousand | 1.4 Million |
| Accounts receivables | 32.45 Thousand | -16.85 Thousand | -67.32 Thousand | -128.84 Thousand | 70.45 Thousand | -49.6 Thousand |
| Accounts payables | 315.84 Thousand | -40.72 Thousand | 621.26 Thousand | -109.84 Thousand | 151.66 Thousand | 344.71 Thousand |
| Inventory | 76.19 Thousand | -19.73 Thousand | 12.58 Thousand | 1841.00 | 1738.00 | 43.8 Thousand |
| Other working capital | 4193.00 | -23.87 Thousand | -77.84 Thousand | 55.77 Thousand | -159.27 Thousand | -7663.00 |
| Cash at beginning of period | 113.06 Thousand | 161.05 Thousand | 27.58 Thousand | 166.18 Thousand | 203.42 Thousand | 32.8 Thousand |
| Cash at end of period | 71.67 Thousand | 113.06 Thousand | 161.05 Thousand | 161.05 Thousand | 166.18 Thousand | 203.42 Thousand |
| Capital Expenditure | -5.00 | 3.00 | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -41.38 Thousand | -47.99 Thousand | 133.47 Thousand | -5121.00 | -37.24 Thousand | 170.62 Thousand |
| Free Cash Flow | -130.28 Thousand | -622.31 Thousand | -2.29 Million | -1.29 Million | -687.75 Thousand | -183.21 Thousand |
2065
9850
LSXMK
1416
APTECHT
603901